Back to AG ADAGE CAPITAL PARTNERS GP, L.L.C.

TCRXTCRX
16 quarters

Position history for AGADAGE CAPITAL PARTNERS GP, L.L.C.'s holdings in TSCAN THERAPEUTICS INC

ADAGE CAPITAL PARTNERS GP, L.L.C. previously held 0 shares of TCRX (TSCAN THERAPEUTICS INC), worth $0 as of 2025-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$4.1M

Total Shares Change

-496,583

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$1.40
0
2025-Q1
Unchanged
3.5M
0.0%
$4.8M0.0%$1.35
0
2024-Q4
Decreased
3.5M
-20.4%
$10.6M0.0%$3.00
0
2024-Q3
Unchanged
4.4M
0.0%
$21.9M0.0%$5.04
0
2024-Q2
Increased
4.4M
+12.8%
$25.7M0.0%$5.85
32
2024-Q1
Unchanged
3.9M
0.0%
$31M0.1%$7.94
0
2023-Q4
Decreased
3.9M
-2.5%
$22.7M0.0%$5.83
0
2023-Q3
Unchanged
4M
0.0%
$10.2M0.0%$2.56
0
2023-Q2
Increased
4M
+627.3%
$10M0.0%$2.54
45
2023-Q1
Unchanged
550,000
0.0%
$1.2M0.0%$2.57
0
2022-Q4
Unchanged
550,000
0.0%
$852,5000.0%$1.55
0
2022-Q3
Unchanged
550,000
0.0%
$1.7M0.0%$3.13
0
2022-Q2
Unchanged
550,000
0.0%
$1.7M0.0%$3.10
0
2022-Q1
Unchanged
550,000
0.0%
$1.5M0.0%$2.91
0
2021-Q4
Increased
550,000
+10.8%
$2.5M0.0%$4.83
29
2021-Q3
New
496,583
-
$4.1M0.0%$8.59
37

Other major holders of TCRX: BlackRock Finance, Inc., BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used